
Multi-omics profiling unravel the immune landscape diversity by prognostic signatures of immunotherapy response in triple-negative breast cancer
<a href="https://news.google.com/rss/articles/CBMikgFBVV95cUxNVXRRdjIwN0Vwc29zcE5PSmtHMk5UQ1FETzRnNF92VlY4ZXBLNW9WT25uR19yd1Fwb2hieG9mOTBXX2l5Y1lvRU9qaDh1aURNWXJRSTZPZVlIcU8tSGd3MzZoVlNLNlZ3WGY3NmtQTE1ReEYwdVRadjNGRmRXbUlmbi1EQ2RhaF9hVHNrVkV5TEc4dw?oc=5" target="_blank">Multi-omics profiling unravel the immune landscape diversity by prognostic signatures of immunotherapy response in triple-negative breast cancer</a>&nbsp;&nbsp;<font color="#6f6f6f">Frontiers</font>
